Blume Capital Management’s Insulet PODD Stock Holding History

Blume Capital Management’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1	Closed	-$263	–	528
2025 Q1	$263	Buy	+1	New	+$271	﹤0.01%	424

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Blume Capital Management's PODD Position: Q2 2025 in Review

Blume Capital Management sold out of Insulet (PODD) in Q2 2025, closing a stake of 1 share — an estimated $263 sold.

Blume Capital Management first reported a position in PODD in Q1 2025 and held it in 1 quarter. The position peaked at $263 in Q1 2025. 796 funds tracked by Wall St. Rank hold PODD as of Q2 2025.

Blume Capital Management reported no remaining Insulet position as of Q2 2025 after selling out during the quarter.
Blume Capital Management sold 1 Insulet share in Q2 2025, an estimated $263.
Blume Capital Management first reported a position in Insulet in Q1 2025 and held it in 1 quarter.
Blume Capital Management's Insulet position peaked at $263 in Q1 2025.
796 funds tracked by Wall St. Rank held Insulet as of Q2 2025.

Based on Blume Capital Management's 13F filing for Q2 2025, filed 30 Jul 2025.